House Antitrust Subcommittee Chair David N. Cicilline (RI-01) released the following statement today after the House Judiciary Committee unanimously passed his bipartisan bill to drive down the costs of prescription drugs, the Affordable Prescriptions for Patients Through Promoting Competition Act of 2019 (H.R. 5133)
House Antitrust Subcommittee Chair David N. Cicilline (RI-01) and Judiciary Committee Chairman Jerrold Nadler (NY-10) introduced The Affordable Prescriptions for Patients Through Promoting Competition Act of 2019 (H.R. 5133) today to prohibit pharmaceutical companies from engaging in anticompetitive “product hopping.”
Democratic Policy and Communications Committee (DPCC) Chair David N. Cicilline (RI-01) issued the following statement today after voting to pass the United States Export Finance Agency Act (H.R.4863).
Welcome to the on-line office for Congressman David Cicilline. Please visit the Contact Me page to contact David electronically or click on the office location nearest you for details.
Get updates on important issues sent
directly to your email address.
Washington, DC
2233 Rayburn HOB
Washington, DC 20515
Phone: (202) 225-4911
Fax: (202) 225-3290
Hours: Monday-Friday 9:00AM-6:00PM Eastern time
